The increasing investment in longevity biotechnology aims to tackle age-related diseases and extend human lifespan. However, the complexities and potential risks associated with manipulating biological aging processes raise important questions about the future of health and long…
A recent study investigates the consequences of alpha-N-acetylglucosaminidase (NAGLU) inactivation on the ultrastructural integrity of epididymal mononuclear phagocytes and epithe…
A recent study from UCLA Health suggests that cognitive behavioral therapy for insomnia (CBT-I) may not only improve sleep in older adults but also slow biological aging. The rese…
Researchers at the FDA's Center for Drug Evaluation and Research (CDER) have created a systematic framework for biomarker discovery utilizing plasma proteomics. This innovative ap…
A 2025 study published in Neurology reveals that older adults with strong, consistent circadian rhythms have nearly half the risk of developing dementia. This research highlights…
A recent study published in PLOS Biology highlights how regional signaling influences stem cell-mediated regeneration in the solitary ascidian Ciona robusta. The research shows th…
A recent study has found that higher levels of vitamin D in the brain are associated with better cognitive performance and a slower decline in thinking abilities as people age. Th…
A recent study highlights the association between long-term exposure to the pesticide chlorpyrifos and a more than 2.5-fold increased risk of developing Parkinson’s disease. This…
The Targeting Aging with Metformin (TAME) trial aims to investigate whether metformin, a widely used diabetes medication, can slow biological aging and extend lifespan. This multi…
Sirtuins are proteins produced by the body that play a crucial role in regulating cellular energy production, DNA repair, and metabolism. These proteins are essential for maintain…
Recent research indicates that semaglutide, a drug used for weight loss, may also extend lifespan and improve health measures in elderly mice. While the findings are intriguing, t…
A recent analysis reveals that prescription rates for GLP-1 weight-loss medications, such as Wegovy and Mounjaro, are significantly lower in England's most deprived areas, despite…